After SunTrust Robinson and Oppenheimer gave LHC Group (NASDAQ: LHCG) a Buy rating last month, the company received another Buy, this time from Jefferies. Analyst Brian Tanquilut reiterated a Buy rating on LHC Group yesterday and set a price target of $120. The company’s shares closed yesterday at $93.58, close to its 52-week high of $93.97.
According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 5.8% and a 55.0% success rate. Tanquilut covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Walgreens Boots Alliance, and Quest Diagnostics Inc.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for LHC Group with a $100.33 average price target, representing a 7.2% upside. In a report issued on August 1, Oppenheimer also maintained a Buy rating on the stock with a $110 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $93.97 and a one-year low of $58.55. Currently, LHC Group has an average volume of 268.8K.
Based on the recent corporate insider activity of 39 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.
